OZEMPIC.BOT
v2.1 · GLP-1 INDEX
OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·OZEMPIC $968.52 ↓ 2.1%·WEGOVY $1,349.02 ↑ 0.4%·MOUNJARO $1,069.08 ↓ 1.8%·ZEPBOUND $1,086.37 → 0.0%·FDA · SHORTAGE RESOLVED · OCT 2024·NOVO NORDISK Q3 REVENUE +29%·ELI LILLY MARKET CAP $720B·COMPOUNDED SEMAGLUTIDE BAN UPDATE·
§ 03

Supply

Live shortage status from FDA drug shortage database, updated hourly.

Ozempic
Status · Limited

Some strengths backordered; pharmacies rotating allocations.

semaglutide
Wegovy
Status · Limited

Some strengths backordered; pharmacies rotating allocations.

semaglutide
Mounjaro
Status · Limited

Some strengths backordered; pharmacies rotating allocations.

tirzepatide
Zepbound
Status · Limited

Some strengths backordered; pharmacies rotating allocations.

tirzepatide
⌗ SourceStatus pulled from FDA Drug Shortage API · Live data · Updated 8:31:36 AM
12-month availability

% of pharmacies reporting in-stock

Ozempic
Wegovy
Mounjaro
Zepbound